Predictors of poor outcomes in juvenile dermatomyositis: what do we know? A narrative review

Area of Science:

• Pediatric Rheumatology
• Systemic Inflammatory Disorders
• Autoimmune Diseases

Background:

• Juvenile dermatomyositis (JDM) is a rare, chronic, systemic inflammatory disease with variable clinical presentations.
• Identifying patients at risk for severe disease progression and poor outcomes is critical for effective management.
• Existing literature lacks comprehensive data on predictors of adverse outcomes in JDM.

Purpose of the Study:

• To identify clinical and laboratory risk factors associated with poor outcomes in juvenile dermatomyositis.
• To inform early identification of high-risk JDM patients for tailored therapeutic strategies.
• To improve the long-term prognosis and reduce morbimortality in children with JDM.

Main Methods:

• A narrative review of scientific literature was performed.
• Twenty-seven articles were systematically included in the review.
• The review focused on identifying risk factors for death, severe disease, refractory disease, and functional impairment in JDM.

Main Results:

• Specific clinical manifestations and immunological features are associated with a worse prognosis in JDM.
• Early recognition of these risk factors is vital for pediatric rheumatologists.
• Identifying at-risk patients enables closer monitoring and aggressive, individualized treatment to reduce severe outcomes.

Conclusions:

• Further research is necessary to discover additional predictors of poor outcomes in JDM.
• Developing more effective, targeted treatment approaches for high-risk JDM patients is essential.
• Enhanced understanding of risk factors can lead to improved management and prognosis for JDM.